“…The rates of MS in our study population were higher in females compared to males. This gender difference is in concordance with other studies [6,9,10,12] and is important to be clearly identified as certain conditions specific to females, such as pregnancy, menopause, polycystic ovarian syndrome, etc. may aggravate cardiovascular risk in association with MS [13].…”
Section: Discussionsupporting
confidence: 92%
“…Prevalence of MS has been reported 19.52 % in Maharashtra, 31.6 % in Rajasthan and 41 % in Tamil Nadu [6,10,11]. As different studies have used dissimilar criteria for diagnosis of MS, the comparison may be unsubstantial.…”
Section: Discussionmentioning
confidence: 99%
“…Prevalence of the MS in Asian Indians varies according to region, extent of urbanization, lifestyle patterns, and socioeconomic/cultural factors [4]. The reported prevalence of MS varies from 20 to 30 % in different regions of Indian [5,6]. There are very few reports on component analysis of MS and their impact in semi-urban populations of Uttarakhand, which is a hill state of India.…”
Metabolic syndrome is a complex of metabolic factors which includes central obesity, insulin-resistance, dyslipidemia and hypertension. Metabolic syndrome is associated with increased risk of cardiovascular disease. This study aimed to know the rate of metabolic syndrome in outpatients presenting to medicine department of our hospital and their profile. The metabolic syndrome was diagnosed using International Diabetes Federation criteria. The parameters analyzed included age, sex, blood pressure, BMI, fasting plasma glucose, HDL and triglycerides. The rate of metabolic syndrome was 21.1 % in our study. The younger population was most susceptible to metabolic derangements. Further, females were found to be affected more than males. The extremely significant parameters were deranged fasting plasma glucose, HDL, triglycerides while hypertension was found to be insignificant. Being overweight maybe a strong predictor for presence of metabolic syndrome in our region of study, and all overweight persons should be assessed and appropriately treated to prevent future cardiovascular events.
“…The rates of MS in our study population were higher in females compared to males. This gender difference is in concordance with other studies [6,9,10,12] and is important to be clearly identified as certain conditions specific to females, such as pregnancy, menopause, polycystic ovarian syndrome, etc. may aggravate cardiovascular risk in association with MS [13].…”
Section: Discussionsupporting
confidence: 92%
“…Prevalence of MS has been reported 19.52 % in Maharashtra, 31.6 % in Rajasthan and 41 % in Tamil Nadu [6,10,11]. As different studies have used dissimilar criteria for diagnosis of MS, the comparison may be unsubstantial.…”
Section: Discussionmentioning
confidence: 99%
“…Prevalence of the MS in Asian Indians varies according to region, extent of urbanization, lifestyle patterns, and socioeconomic/cultural factors [4]. The reported prevalence of MS varies from 20 to 30 % in different regions of Indian [5,6]. There are very few reports on component analysis of MS and their impact in semi-urban populations of Uttarakhand, which is a hill state of India.…”
Metabolic syndrome is a complex of metabolic factors which includes central obesity, insulin-resistance, dyslipidemia and hypertension. Metabolic syndrome is associated with increased risk of cardiovascular disease. This study aimed to know the rate of metabolic syndrome in outpatients presenting to medicine department of our hospital and their profile. The metabolic syndrome was diagnosed using International Diabetes Federation criteria. The parameters analyzed included age, sex, blood pressure, BMI, fasting plasma glucose, HDL and triglycerides. The rate of metabolic syndrome was 21.1 % in our study. The younger population was most susceptible to metabolic derangements. Further, females were found to be affected more than males. The extremely significant parameters were deranged fasting plasma glucose, HDL, triglycerides while hypertension was found to be insignificant. Being overweight maybe a strong predictor for presence of metabolic syndrome in our region of study, and all overweight persons should be assessed and appropriately treated to prevent future cardiovascular events.
“…Therefore, the differences may in part be due Our results demonstrate a remarkably higher prevalence of MS in Turkish population when using the ATP III definition. The prevalence is higher when compared with Americans, Koreans, Chinese, Japanese, Mongolians (Ford et al, 2002;Kim et al, 2004;Lee et al, 2004;Duc Son et al, 2005;Enkhmaaa et al, 2005;Thomas et al, 2005) and comparable to that of Mexican Americans, South Asians and Persians (Ford et al, 2002;Azizi et al, 2003;Ramachandran et al, 2003;Gupta et al, 2004). Turkish population has one of the world's highest prevalences of MS, comparable to that of the South Asians.…”
Section: Ethnic and Country Differences In Ms Prevalencementioning
confidence: 92%
“…Although obesity and level of physical activity contribute significantly to the frequency of MS, other factors, such as a genetic predisposition, may play a role (Abate, 2000;Thomas et al, 2000;Das, 2002). Studies performed in various ethnic groups have also shown that the frequency of individual components of MS can vary between countries (Ford et al, 2002;Onat and Sansoy, 2002;Azizi et al, 2003;Ramachandran et al, 2003;Chuang et al, 2004;Gupta et al, 2004;Kim et al, 2004;Lee et al, 2004;Duc Son et al, 2005;Enkhmaaa et al, 2005;Thomas et al, 2005).…”
Objective: To determine prevalence of the metabolic syndrome (MS) in a sample representing Turkish population using United States Adult Treatment Panel-3 guidelines. Design: The study included random samples from both urban and rural populations in the seven geographical regions of Turkey. The population for this analysis were 2108 men (1372 in urban and 736 in rural areas) and 2151 women (1423 in urban and 728 in rural areas) with a mean age of 40.9714.9 years (range 20-90). Results: The prevalence of the MS diagnosed using the Adult Treatment Panel III criteria was 33.9% (1442 of 4259) and differed significantly in men (28%) and women (39.6%). The prevalence of syndrome increased with age in men, from 10.7% in subjects aged 20-29 years to 49% in those aged over 70 years. The prevalence increased with age in women, from 9.6% in subjects aged 20-29 years to 74.6% in those aged 60-69 years, and decreased to 68.6% in those over 70 years of age. The prevalence of the syndrome was similar in urban (33.8%) and rural (33.9%) population. We found 26.8, 26.4, 19.3, 10.9 and 3.6% of the population had at least 1, 2, 3, 4 or 5 components, respectively. We found 57.2, 32.3 and 10.6% of the subjects with MS had 3, 4 and 5 components, respectively.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.